Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 197

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Mechanisms of Bioactivities of Fucoidan from the Brown Seaweed Fucus vesiculosus L. of the Barents Sea

Open access
Pozharitskaya, Olga N., Obluchinskaya, Ekaterina D., Shikov, Alexander N.·2020·Marine Drugs

Abstract

The aim of this study was to elucidate some mechanisms of radical scavenging and the anti-inflammatory, anti-hyperglycemic, and anti-coagulant bioactivities of high molecular weight fucoidan from Fucus vesiculosus in several in vitro models. Fucoidan has displayed potent 1, 1-diphenyl-2-picryl hydrazil radical scavenging and reduction power activities. It significantly inhibits the cyclooxygenase-2 (COX-2) enzyme (IC50 4.3 μg mL−1) with a greater selectivity index (lg(IC80 COX-2/IC80COX-1), −1.55) than the synthetic non-steroidal anti-inflammatory drug indomethacin (lg(IC80 COX-2/IC80COX-1), −0.09). A concentration-dependent inhibition of hyaluronidase enzyme with an IC50 of 2.9 μg mL−1 was observed. Fucoidan attenuated the lipopolysaccharide-induced expression of mitogen-activated protein kinase p38. Our findings suggest that the inhibition of dipeptidyl peptidase-IV (DPP-IV) (IC50 1.11 μg mL−1) is one of the possible mechanisms involved in the anti-hyperglycemic activity of fucoidan. At a concentration of 3.2 μg mL−1, fucoidan prolongs the activated partial thromboplastin time and thrombin time by 1.5-fold and 2.5-fold compared with a control, respectively. A significant increase of prothrombin time was observed after the concentration of fucoidan was increased above 80 μg mL−1. This evidenced that fucoidan may have an effect on intrinsic/common pathways and little effect on the extrinsic mechanism. This study sheds light on the multiple pathways of the bioactivities of fucoidan. As far as we know, the inhibition of hyaluronidase and DPP-IV by high molecular fucoidan was studied for the first time in this work. Our results and literature data suggest that molecular weight, sulfate content, fucose content, and polyphenols may contribute to these activities. It seems that high molecular weight fucoidan has promising therapeutic applications in different pharmacological settings. Anti-oxidant, anti-inflammatory and anti-coagulant drugs have been used for the management of complications of COVID19. Taken as a whole, fucoidan could be considered as a prospective candidate for the treatment of patients with COVID19; however, additional research in this field is required.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/md18050275

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 68

  1. Mayer, A.M.S., Guerrero, A.J., Rodríguez, A.D., Taglialatela-Scafati, O., Nakamura, F., and Fusetani, N. (2020). Marine pharmacology in 2014–2015: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, antiviral, and anthelmintic activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action. Mar. Drugs, 18. · DOI
  2. Usov, 2009, Fucoidans—Sulfated polysaccharides of brown algae, Russ. Chem. Revs., 78, 785, 10.1070/RC2009v078n08ABEH004063 · DOI
  3. Ushakova, 2008, Anticoagulant activity of fucoidans from brown algae, Biomed. Khim., 54, 597
  4. Wang, 2008, Antioxidant activity of sulfated polysaccharide fractions extracted from Laminaria japonica, Int. J. Biol. Macromol., 42, 127, 10.1016/j.ijbiomac.2007.10.003 · DOI · Paper page
  5. Wang, Y., Xing, M., Cao, Q., Ji, A., Liang, H., and Song, S. (2019). Biological activities of fucoidan and the factors mediating its therapeutic effects: A review of recent studies. Mar. Drugs, 17. · DOI · Paper page
  6. Koh, 2019, Structure characterization and antioxidant activity of fucoidan isolated from Undaria pinnatifida grown in New Zealand, Carbohydr. Polym., 212, 178, 10.1016/j.carbpol.2019.02.040 · DOI · Paper page
  7. Fernando, 2018, Antioxidant and anti-inflammatory functionality of ten Sri Lankan seaweed extracts obtained by carbohydrase assisted extraction, Food Sci. Biotechnol., 27, 1761, 10.1007/s10068-018-0406-1 · DOI
  8. Yang, 2017, Inhibitory effect of fucoidan on hypoglycemia in diabetes mellitus anim, Int. J. Clin. Exp. Med., 10, 8529
  9. Fernando, 2020, Therapeutic potential of algal natural products against metabolic syndrome: A review of recent developments, Trends Food Sci. Technol., 97, 286, 10.1016/j.tifs.2020.01.020 · DOI
  10. Irhimeh, 2009, Pilot clinical study to evaluate the anticoagulant activity of fucoidan, Blood Coagul. Fibrinolysis, 20, 607, 10.1097/MBC.0b013e32833135fe · DOI
  11. Wang, 2011, In vitro anticoagulant activity of fucoidan derivatives from brown seaweed Laminaria japonica, Chin. J. Oceanol. Limnol., 29, 679, 10.1007/s00343-011-0181-9 · DOI
  12. Zhao, 2016, Antithrombotic activity of oral administered low molecular weight fucoidan from Laminaria japonica, Thromb. Res., 144, 46, 10.1016/j.thromres.2016.03.008 · DOI
  13. Krylova, N.V., Ermakova, S.P., Lavrov, V.F., Leneva, I.A., Kompanets, G.G., Iunikhina, O.V., Nosik, M.N., Ebralidze, L.K., Falynskova, I.N., and Silchenko, A.S. (2020). The comparative analysis of antiviral activity of native and modified fucoidans from brown algae Fucus evanescens in vitro and in vivo. Mar. Drugs, 18. · DOI
  14. Pozharitskaya, O.N., Shikov, A.N., Faustova, N.M., Obluchinskaya, E.D., Kosman, V.M., Vuorela, H., and Makarov, V.G. (2018). Pharmacokinetic and tissue distribution of fucoidan from Fucus vesiculosus after oral administration to rats. Mar. Drugs, 16. · DOI
  15. Oka, 2020, Properties of fucoidans beneficial to oral healthcare, Odontology, 108, 34, 10.1007/s10266-019-00437-3 · DOI
  16. Fitton, 2015, Topical benefits of two fucoidan-rich extracts from marine macroalgae, Cosmetics, 2, 66, 10.3390/cosmetics2020066 · DOI
  17. Chakraborty, 2016, Characterization of substituted aryl meroterpenoids from red seaweed Hypnea musciformis as potential antioxidants, Food Chem., 212, 778, 10.1016/j.foodchem.2016.06.039 · DOI
  18. Zhang, 2015, Antioxidant phytochemicals for the prevention and treatment of chronic diseases, Molecules, 20, 21138, 10.3390/molecules201219753 · DOI · Paper page
  19. Holgate, 2003, Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling, J. Allergy Clin. Immunol., 111, 18, 10.1067/mai.2003.25 · DOI · Paper page
  20. Kumar, 2011, High-through screening assays for cyclooxygenase-2 and 5-lipoxygenase, the targets for inflammatory disorders, Ind. J. Biochem. Biophys., 48, 256
  21. Saklatvala, 2004, The p38 MAP kinase pathway as a therapeutic target in inflammatory disease, Curr. Opin. Pharmacol., 4, 372, 10.1016/j.coph.2004.03.009 · DOI · Paper page
  22. Yang, 2003, Transcriptional regulation by the MAP kinase signaling cascades, Gene, 320, 3, 10.1016/S0378-1119(03)00816-3 · DOI · Paper page
  23. Katsube, 2003, Hyaluronidase-inhibiting polysaccharide isolated and purified from hot water extract of sporophyll of Undaria pinnatifida, Food Sci. Technol. Res., 9, 25, 10.3136/fstr.9.25 · DOI
  24. Elzoghby, A.O., Freag, M.S., and Elkhodairy, K.A. (2018). Biopolymeric nanoparticles for targeted drug delivery to brain tumors. Nanotechnology-Based Targeted Drug Delivery Systems for Brain Tumors, Elsevier. · DOI
  25. Havale, 2009, Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes, Bioorg. Med. Chem., 17, 1783, 10.1016/j.bmc.2009.01.061 · DOI · Paper page
  26. Bruhn, 1997, Anticoagulant fucoidan fractions from fucus vesiculosus induce platelet activation in vitro, Thromb. Res., 85, 479, 10.1016/S0049-3848(97)00037-6 · DOI
  27. Zayed, A., Muffler, K., Hahn, T., Rupp, S., Finkelmeier, D., Burger-Kentischer, A., and Ulber, R. (2016). Physicochemical and biological characterization of fucoidan from Fucus vesiculosus purified by dye affinity chromatography. Mar. Drugs, 14. · DOI
  28. Lahrsen, 2018, Size-dependent pharmacological activities of differently degraded fucoidan fractions from Fucus vesiculosus, Carbohydr. Polym., 189, 162, 10.1016/j.carbpol.2018.02.035 · DOI
  29. Jönsson, M., Allahgholi, L., Sardari, R.R., Hreggviðsson, G.O., and Nordberg Karlsson, E. (2020). Extraction and modification of macroalgal polysaccharides for current and next-generation applications. Molecules, 25. · DOI · Paper page
  30. Luthuli, S., Wu, S., Cheng, Y., Zheng, X., Wu, M., and Tong, H. (2019). Therapeutic effects of fucoidan: A review on recent studies. Mar. Drugs, 17. · DOI · Paper page
  31. Fletcher, 2017, The seasonal variation of fucoidan within three species of brown macroalgae, Algal Res., 22, 79, 10.1016/j.algal.2016.10.015 · DOI · Paper page
  32. Seyoum, 2006, Structure–radical scavenging activity relationships of flavonoids, Phytochemistry, 67, 2058, 10.1016/j.phytochem.2006.07.002 · DOI · Paper page
  33. Lim, 2014, Isolation and antioxidant capacity of fucoidan from selected Malaysian seaweeds, Food Hydrocoll., 42, 280, 10.1016/j.foodhyd.2014.03.007 · DOI · Paper page
  34. Mussatto, 2014, Chemical composition and antioxidant activity of sulphated polysaccharides extracted from Fucus vesiculosus using different hydrothermal processes, Chem. Pap., 68, 203
  35. Le, 2007, Identification and quantification of antioxidants in Fructus lycii, Food Chem., 105, 353, 10.1016/j.foodchem.2006.11.063 · DOI · Paper page
  36. He, J., Xu, Y., Chen, H., and Sun, P. (2016). Extraction, structural characterization, and potential antioxidant activity of the polysaccharides from four seaweeds. Int. J. Mol. Sci., 17. · DOI · Paper page
  37. Zayed, A., and Ulber, R. (2020). Fucoidans: Downstream processes and recent applications. Mar. Drugs, 18. · DOI
  38. Yang, 2011, In vitro antioxidant activities of sulfated polysaccharide fractions extracted from Corallina officinalis, Int. J. Biol. Macromol., 49, 1031, 10.1016/j.ijbiomac.2011.08.026 · DOI
  39. Zayed, 2019, Phenomenological investigation of the cytotoxic activity of fucoidan isolated from Fucus vesiculosus, Process Biochem., 81, 182, 10.1016/j.procbio.2019.03.026 · DOI
  40. 2019, Influence of molecular weight on the properties of Sargassum muticum fucoidan, Algal Res., 38, 101393, 10.1016/j.algal.2018.101393 · DOI
  41. Mak, 2013, Fucoidan from New Zealand Undaria pinnatifida: Monthly variations and determination of antioxidant activities, Carbohydr. Polym., 95, 606, 10.1016/j.carbpol.2013.02.047 · DOI · Paper page
  42. Somasundaram, 2016, Cytotoxic effect of fucoidan extracted from Sargassum cinereum on colon cancer cell line HCT-15, Int. J. Biol. Macromol., 91, 1215, 10.1016/j.ijbiomac.2016.06.084 · DOI
  43. Wang, 2009, Total phenolic compounds, radical scavenging and metal chelation of extracts from Icelandic seaweeds, Food Chem., 116, 240, 10.1016/j.foodchem.2009.02.041 · DOI · Paper page
  44. Parys, 2010, In vitro chemopreventive potential of fucophlorethols from the brown alga Fucus vesiculosus L. by anti-oxidant activity and inhibition of selected cytochrome P450 enzymes, Phytochemistry., 71, 221, 10.1016/j.phytochem.2009.10.020 · DOI
  45. Jouzeau, 1997, Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs, Drugs, 53, 563, 10.2165/00003495-199753040-00003 · DOI · Paper page
  46. Park, 2011, Anti-inflammatory effects of fucoidan through inhibition of NF-κB, MAPK and Akt activation in lipopolysaccharide-induced BV2 microglia cells, Food Chem. Toxicol., 49, 1745, 10.1016/j.fct.2011.04.020 · DOI · Paper page
  47. Dewi, 2016, In silico analysis of the potential of the active compounds fucoidan and alginate derived from Sargassum sp. as inhibitors of COX-1 and COX-2, Med Arch., 70, 172, 10.5455/medarh.2016.70.172-176 · DOI
  48. Lee, 2012, Molecular characteristics and anti-inflammatory activity of the fucoidan extracted from Ecklonia cava, Carbohydr. Polym., 89, 599, 10.1016/j.carbpol.2012.03.056 · DOI · Paper page
  49. Phull, 2017, In vitro and in vivo evaluation of anti-arthritic, antioxidant efficacy of fucoidan from Undaria pinnatifida (Harvey) Suringar, Int. J. Biol. Macromol., 97, 468, 10.1016/j.ijbiomac.2017.01.051 · DOI
  50. Lim, 2015, Fucoidan from Fucus vesiculosus protects against alcohol-induced liver damage by modulating inflammatory mediators in mice and HepG2 cells, Mar. Drugs, 13, 1051, 10.3390/md13021051 · DOI
  51. Rosoiu, 2008, Original bioactive complexes rich in glycosaminoglycans obtained from small fish, Roum. Soc. Biol. Sci., 13, 3944
  52. Kim, 2010, Fucoidan, a sulfated polysaccharide, inhibits adipogenesis through the mitogen-activated protein kinase pathway in 3T3-L1 preadipocytes, Life Sci., 22, 791, 10.1016/j.lfs.2010.03.010 · DOI
  53. Sanjeewa, 2017, Anti-inflammatory activity of a sulfated polysaccharide isolated from an enzymatic digest of brown seaweed Sargassum horneri in RAW 264.7 cells, Nutr. Res. Pract., 11, 3, 10.4162/nrp.2017.11.1.3 · DOI · Paper page
  54. Unnikrishnan, P.S., Suthindhiran, K., and Jayasri, M.A. (2014). Inhibitory potential of Turbinaria ornata against key metabolic enzymes linked to diabetes. BioMed Res. Int. · DOI
  55. Unnikrishnan, 2015, Antidiabetic potential of marine algae by inhibiting key metabolic enzymes, Front. Life Sci., 8, 148, 10.1080/21553769.2015.1005244 · DOI
  56. Wheeler, 2016, The intrinsic pathway of coagulation as a target for antithrombotic therapy, Hematol. Oncol. Clin. North Am., 30, 1099, 10.1016/j.hoc.2016.05.007 · doi:10.1016/j.hoc.2016.05.007
  57. Chen, 2015, Sulfated polysaccharides isolated from cloned Grateloupia filicina and their anticoagulant activity, BioMed Res. Int., 2015, 612352
  58. Athukorala, 2008, Evaluation of biomolecular interactions of sulfated polysaccharide isolated from Grateloupia filicina on blood coagulation factors, J. Microbiol. Biotechnol., 18, 503
  59. Zhang, 2015, Screening of complex fucoidans from four brown algae species as procoagulant agents, Carbohydr. Polym., 115, 677, 10.1016/j.carbpol.2014.09.001 · DOI
  60. Obluchinsksya, 2015, Effects of ultrasound treatment on the chemical composition and anticoagulant properties of dry Fucus extract, Pharm. Chem. J., 49, 183, 10.1007/s11094-015-1250-8 · DOI
  61. Thanh, 2013, Structure of fucoidan from brown seaweed Turbinaria ornata as studied by electrospray ionization mass spectrometry (ESIMS) and small angle X-ray scattering (SAXS) techniques, Mar. Drugs, 11, 2431, 10.3390/md11072431 · DOI
  62. Imbs, 2015, Antioxidant activity of fucose-containing sulfated polysaccharides obtained from Fucus evanescens by different extraction methods, J. Appl. Phycol., 27, 545, 10.1007/s10811-014-0293-7 · DOI
  63. Akbarov, 2020, Metabolite profiling and mechanisms of bioactivity of snake autolysate—A traditional Uzbek medicine, J. Ethnopharmacol., 250, 112459, 10.1016/j.jep.2019.112459 · doi:10.1016/j.jep.2019.112459
  64. Anderson, 1976, Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtration, Thromb. Res., 9, 575, 10.1016/0049-3848(76)90105-5 · DOI · Paper page
  65. Quick, 1940, The clinical application of the hippuric acid and the prothrombin tests, Am. J. Clin. Pathol., 10, 222, 10.1093/ajcp/10.3.222 · DOI · Paper page
  66. Denson, 1973, The measurement of heparin: A method based on the potentiation of anti-factor Xa, Thromb. Haemost., 30, 471, 10.1055/s-0038-1649125 · DOI
  67. Wang, J.Z., Zhang, R.Y., and Bai, J. (2020). An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients. Int. J. Cardiol. · DOI
  68. Thachil, J., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M., Clarck, C., and Iba, T. (2020). ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J. Thromb. Haemost. · DOI · Paper page

Cited by

See all 197

Metadata

Authors
Pozharitskaya, O. N., Obluchinskaya, E. D., & Shikov, A. N.
Venue
Marine Drugs
Publisher
MDPI AG
Published
2020-05-22
Volume
18
Issue
5
Pages
275
ISSN
1660-3397 (ISSN-L)
OpenAlex
W3026787770
Cited by
197
References
12
FWCI
19.34
Type
journal article
Language
en
Open access
gold
Funders
State Task of MMBI KSC RAS, Ministry of Education and Science of the RF (01201453843)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanisms of Bioactivities of Fucoidan from the Brown Seaweed Fucus vesiculosus L. of the Barents Sea. https://app.cochat.ai/papers/10.3390/md18050275
The paper
Pozharitskaya, O. N., Obluchinskaya, E. D., & Shikov, A. N. (2020). Mechanisms of Bioactivities of Fucoidan from the Brown Seaweed Fucus vesiculosus L. of the Barents Sea. Marine Drugs. https://doi.org/10.3390/md18050275

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.